Morrisville, N.C. – August 21, 2018 – Q2 Solutions, a global clinical trials laboratory services organization, announced today the addition of its new Immunoanalytical Scientific Director and Site Lead, Dr. Michael Brown.
As the new Scientific Director and Site Lead, Dr. Brown will be responsible for a broad range of oversight of our immunoanalytical laboratory operations in Marietta, Georgia. This includes scientific oversight of our work conducted for PK, ADA and Neutralizing Antibody work for our global client base. Dr. Brown will also be engaged across our global laboratory network in helping to lead and guide our innovation, technology and scientific execution of work in the field of large molecule bioanalysis.
“We are pleased and excited to have Mike on our team. With his depth and breadth of scientific knowledge; and, years of industry experience and regulatory knowledge, his addition to our team is a key catalyst for growth and expansion in the future,” said Kevin Jones, Q2 Solutions Vice President and General Manager of Bioanalytical and ADME Laboratories. “Mike will be instrumental in executing our existing growth strategy and will also provide valued insights and leadership as we enter into our next phase of growth for the future in the expanding market for large molecule bioanalysis globally.”
Dr. Brown brings more than 20 years of experience in the contract research organization and life science sector, with the last 10 years holding positions of increasing responsibility in bioanalytical and immunoassay operations at ICON Laboratories, Inc. Most recently, Dr. Brown served as Managing Director and Site Head of ICON Bioanalytical Laboratories, where he was responsible for the implementation of scientific and organizational quality for regulated bioanalysis.
Click here to learn more about how Q2 Solutions partners with customers to accelerate and enhance discovery, preclinical and clinical programs.
About Q2 Solutions
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. As one of the largest bioanalytical and ADME service providers in the world, Q2 Solutions excels at large-scale screening using in-house or client-customized protocols with rapid turnaround. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.